1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow LY01005: new trials by email Literature Review of LY01005 trials Research Report on LY01005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® LY01005, ZOLADEX® 3.6 mg - Breast Cancer | Phase 3 | Completed | Luye Pharma Group Ltd. | 188 | 2020-10-15 | 2023-05-16 |
Breast Neoplasms (1)
China (1)